Benylan 2.8 mg/ml oral solution

Benylan is a well-known medicinal brand used primarily as a cough suppressant and allergy relief treatment. It contains the active ingredient Diphenhydramine hydrochloride. The brand has a long history in the pharmaceutical industry and is recognized for its effectiveness in treating symptoms like dry cough, hay fever, and hives.

Historically, Benylan was part of the Warner-Lambert portfolio before it was acquired by Pfizer. In 2006, Johnson & Johnson acquired Pfizer's Consumer Healthcare division, bringing Benylan under its umbrella. Following a corporate spin-off in 2023, the brand is now owned by Kenvue, which is the world's largest pure-play consumer health company by revenue.

While manufacturing takes place in various global facilities to meet regional market requirements, much of the production for the European market is centered in France at dedicated consumer health pharmaceutical plants. The product shown features labeling in Danish and Icelandic, indicating it is distributed specifically for the Nordic markets.